A year after the onslaught of the global pandemic, FPI inflows, corporate
performance, and news of the vaccines were key to the Indian equity markets’
immunity against Covid-19.
The Covid-19 pandemic failed to affect the bulls’ spirits, as benchmark indices saw absolute annual gains between 75.2% and 117.2% while FPIs pumped in a record ₹2.74 lakh crore into equities.
The pandemic, ultimately, was unsuccessful in denting the country's capital raising confidence, as India Inc. raised over ₹1.88 lakh crore, beating the record of over ₹1.75 lakh crore raised in FY18.
Rising inflation and firming bond yields in the U.S. push down Indian benchmark indices, causing a correction of around 6% from the latest life–highs of February 16.
Though equity MFs witnessed the seventh consecutive month of net outflows in January, AMFI's chief executive says investors will continue to tap MFs as a handy route for wealth creation.
Absence of new taxes, no tweaking of older ones, infrastructure capex focus, and stronger disinvestment intent boosts equity indices, with the Sensex recording its best Budget-day gains since 1997.
Despite the Survey’s positive tone, the Sensex and Nifty 50 closed in the red, falling nearly 8% in a matter of five trading sessions from their January 21 life–high.
While the year was marred by the Covid-19 pandemic, lockdowns, and negative GDP, the equity benchmark indices, however, saw record highs. Will the trend continue in 2021 too?
